SARS-CoV-2 3CLpro-IN-21 (Compound D6) irreversibly and covalently inhibits SARS-CoV-2 3CLpro with an IC50 of 0.03 µM. SARS-CoV-2 3CLpro-IN-21 also inhibits SARS-CoV-13CLpro with an IC50 of 0.12µM[1].
Molecular Weight:
364.22
Formula:
C14H10BrN3O2S
Target:
SARS-CoV,Virus Protease
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted